Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Non-cash Items (2016)

Historic Non-cash Items for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Q4 2016 value amounting to $37465.0.

  • Viridian Therapeutics, Inc.\DE's Non-cash Items fell 5197.35% to $37465.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $37465.0, marking a year-over-year decrease of 5197.35%. This contributed to the annual value of $37465.0 for FY2016, which is 5197.35% down from last year.
  • As of Q4 2016, Viridian Therapeutics, Inc.\DE's Non-cash Items stood at $37465.0, which was down 5197.35% from $262194.0 recorded in Q3 2016.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Non-cash Items ranged from a high of $407000.0 in Q1 2015 and a low of $2000.0 during Q2 2015
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Non-cash Items averaged around $167293.2, with its median value being $132378.0 (2016).
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Non-cash Items tumbled by 8009.97% in 2015 and then soared by 733990.0% in 2016.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's Non-cash Items (Quarter) stood at $392000.0 in 2014, then plummeted by 80.1% to $78009.0 in 2015, then plummeted by 51.97% to $37465.0 in 2016.
  • Its Non-cash Items stands at $37465.0 for Q4 2016, versus $262194.0 for Q3 2016 and $148798.0 for Q2 2016.